Pfizer Inc. (FRA:PFE)
Germany
· Delayed Price · Currency is EUR | Market Cap | 122.11B |
| Revenue (ttm) | 54.48B |
| Net Income (ttm) | 9.18B |
| Shares Out | n/a |
| EPS (ttm) | 1.62 |
| PE Ratio | 13.31 |
| Forward PE | 9.04 |
| Dividend | 1.55 (7.21%) |
| Ex-Dividend Date | Jul 25, 2025 |
| Volume | 6,402 |
| Average Volume | 48,542 |
| Open | 21.50 |
| Previous Close | 21.50 |
| Day's Range | 21.32 - 21.73 |
| 52-Week Range | 18.57 - 27.77 |
| Beta | n/a |
| RSI | 55.94 |
| Earnings Date | Aug 5, 2025 |
About Pfizer
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]
Financial Performance
In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.
Financial numbers in USD Financial StatementsNews
Pfizer shares jump over 5% as Q1 net profit surges 27.2% YoY
Pfizer Ltd’s shares surged 5.4% to ₹5,385 in early trade on Thursday after the pharmaceutical company reported robust first-quarter results for FY26. The company’s net profit grew 27.2% year-on-year (...
FDA considers revoking Pfizer COVID vaccine for children under 5
The Food and Drug Administration is considering revoking the authorization of Pfizer’s COVID-19 vaccine for healthy children under 5 years old, a move that would add another barrier for parents who wa...
July Readers Tagged 9 Ideal Dividend Dogs From 17 "Safer" Of 40 ReFa/Ro Mentions
Prior to July 31, 2025, my REaders mentioned 40 equities in their comments about my articles. Some bad-news investments (ROgues) mixed with (mostly) FAvorites. Thus, readers spoke-up about their ReFa/...
FDA may pull authorization for Pfizer COVID shot for kids under 5
The Food and Drug Administration (FDA) is considering revoking the authorization of Pfizer’s COVID-19 vaccine for healthy children under 5 years old, the company confirmed Wednesday. The move would ad...
FDA may revoke Pfizer COVID-19 vaccine authorization for kids under certain age
The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.
3 Reasons Pfizer's 7%-Yielding Dividend Is Getting Safer
This big pharma company's juicy dividend is looking even more attractive.
FDA may pull authorization of Pfizers Covid vaccine for children under 5
The potential move to rescind authorization of Pfizer's vaccine could leave some kids in the U.S. with no available shots against Covid.
4 stocks to watch on Tuesday: ONON, SE, INTC, PFE
Pfizer/BioNTech may not win FDA renewal for pediatric COVID shot: report
Pfizer, Astellas post late-stage trial win for Padcev with Merck’s Keytruda in bladder cancer
Pfizer's combination therapy improves survival in bladder cancer trial
Pfizer said on Tuesday its cancer drug Padcev, in combination with Merck's Keytruda, significantly improved survival rates in patients with muscle-invasive bladder cancer when administered before and ...
PADCEV Plus KEYTRUDA Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery
Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced positive topline results from the Phase 3 EV-303 clinical trial (also known a...
PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery
PADCEV plus KEYTRUDA is the first and only regimen to improve survival when used before and after standard of care (surgical cystectomy) in cisplatin-ineligible patients with muscle-invasive bladder c...
PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery
NEW YORK & TOKYO--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced positive topline results from the Phase 3 ...
Pfizer shares jump over 2% after launch of next-gen 20-valent pneumococcal vaccine in India
Shares of Pfizer Limited rose 2.07% to Rs 5,165.50 on Tuesday, August 12, following the company’s announcement of the launch of its next-generation 20-valent Pneumococcal Polysaccharide Conjugate Vacc...
Pfizer Just Beat Its Earning Estimates. Is This the Beginning of a Turnaround for the Pharmaceutical Stock?
It was a rare breath of fresh air for shareholders.
FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply
View Preview Pfizer Inc.'s (NYSE: PFE) COVID-19 vaccine for children under five may lose U.S. Food and Drug Administration authorization this fall, raising the possibility of supply shortages and pro...
FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply
Pfizer Inc.'s PFE COVID-19 vaccine for children under five may lose U.S. Food and Drug Administration authorization this fall, raising the possibility of supply shortages and prompting Moderna Inc. MR...
Pfizer's Options Frenzy: What You Need to Know
Whales with a lot of money to spend have taken a noticeably bullish stance on Pfizer . Looking at options history for Pfizer (NYSE: PFE) we detected 13 trades. If we consider the specifics of each tr...
Is This Ultra-High Yield Dividend Stock a Steal at a 19% Discount?
A Fallen Giant Pfizer (NYSE:PFE) has been a bitter pill for investors to swallow. Down 19% from its 52-week high of $30.43 per share, PFE stock has plummeted over 50% in the past three years, a stark ...
RFK Jr has slashed vaccine research. You need to know how perilous that is for the world | Devi Sridhar
The avian flu virus is now just one mutation away from easier transmission among humans. Donald Trump’s health chief is a grave risk to world health Prof Devi Sridhar is chair of global public health ...
Pfizer (PFE) Sees Stock Uptick After Q2 Financial Strength
Pfizer (PFE) Sees Stock Uptick After Q2 Financial Strength
Notable healthcare headlines for the week: Pfizer, Eli Lilly, UnitedHealth in focus
Pfizer Covid vaccine for young children may not be renewed by FDA
Email obtained by Guardian says Pfizer was told approval may not be granted, meaning Moderna may have to fill gap Pfizer’s Covid vaccine for young children may not be renewed by the US Food and Drug A...